Interim FDA Commissioner Announced

Dr. Robert Califf’s tenure as commissioner of the United States Food and Drug Administration (FDA) is slated to come to an end ahead of the January 20th inauguration of Donald Trump as president. Deputy commissioner Dr. Stephen Ostroff is expected to take over on an interim basis after the inauguration. Ostroff has previously been acting commissioner – from April 2015 to February 2016 he served as acting commissioner. Once Califf was sworn in, Ostroff became the FDA’s deputy commissioner for foods and veterinary medicine. Califf Permanent Replacement Scott Gottlieb The leading candidate to replace Califf is said to be Dr. Scott Gottlieb, an Obamacare opponent who’s also a former deputy commissioner at the federal safety watchdog. Gottlieb, currently a fellow at the American Enterprise Institute, is also an assistant professor at the New York University School of Medicine and a former practicing physician and hospitalist. While at the FDA, Gottlieb served as a senior advisor for medical technology, director of medical policy development and deputy commissioner for medical and scientific affairs. Before that, he was a senior policy advisor at the Centers for Medicare & Medicaid Services (CMS). Jim O’Neill Mr. Trump is also expected to be considering Jim O’Neill, a libertarian and Silicon Valley investor with no medical experience (a fact that has some healthcare experts concerned). O’Neill has also previously made controversial statements about the feder...
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs